Providing the technical support needed to screen and develop, register and steward new and existing innovative products that can contribute to better health while minimizing the impact on the environment.
From GLP and cGMP studies to contaminant and packaging investigations, we are ready to support every phase of your product's lifecycle.
We respond to global regulatory challenges by providing testing services in support of product registration, safety and hazard assessment, and environmental risk determination.
We apply advanced analytical methodologies and develop innovative test systems for product development and environmental challenges.
Biological evaluation is a crucial process in the discovery, development and registration of all crop and plant protection products, and specialty products.
We evaluate the intrinsic properties and behaviour of chemical active substances and formulations, and to confirm identity of active substances in plant protection products.
We offer end-to-end seamless experience to our customers with a range of data and logistics services.
Establishing that a plant protection product poses a low risk to human health and safety is of paramount importance in order to successfully register and market the product on a global basis.
In a dynamic and complex regulatory environment, our priority is to support clients through every stage of their registration requirements.
With comprehensive knowledge of laboratory and field studies, our scientists work together to respond quickly, using the most current approach to complex, in-depth environmental studies.
Our aim is to provide the highest quality service, supporting your company in developing superior germplasm and adapted elite varieties, helping to ensure a successful outcome in target markets.
Environmental risk assessment for human and veterinary medicines, delivering robust evidence for regulatory dossiers.
Enabling science. Ensuring compliance. Safeguarding ecosystems.
Eurofins Agroscience Services supports human and veterinary medicinal product developers with end-to-end ERA programmes that meet the latest EMA requirements and global expectations.
Our approach combines deep substance understanding, advanced analytics, and efficient GLP execution, from analytical characterisation and radiolabelled fate to OECD ecotox batteries and EMA Module 1.6 reporting.
We deliver clear, defensible science to keep your development on track and your dossiers compliant — efficiently and sustainably.
We design and execute Phase I → Phase II ERA programmes per EMA guideline, covering PEC assessment, environmental fate, ecotoxicology, and risk mitigation as required for new MAAs, for variations / extensions as well as for Generics & Legacy APIs.
We align study designs with EMA’s tiered decision tree (Phase I PECsw threshold and tailored routes for endocrineactive substances, antibiotics, secondary poisoning) to ensure relevance and 3R principles.
Before designing any study, we thoroughly explore the substance profile with analytical fingerprinting, impurity/metabolite mapping, and mode of action. This early analytical deep‑dive ensures fit-for-purpose, efficient, and scientifically justified study programmes — reducing avoidable testing and improving.
We offer unrivalled capabilities for quantification, impurity profiling, metabolite identification, radiolabel tracking, and structure elucidation.
We run OECD/ISO/EPA‑aligned studies on algae, daphnia, fish, soil organisms, biodegradability etc, tailored to EMA’s tiered triggers and refinement steps, compliant with Good Laboratory Practices (GLP).